Roivant Sciences Ltd ROIV on Thursday secured U.S. Food and Drug Administration approval for LISRAYA (brepocitinib) 30 mg, a ...
Cassava Sciences (SAVA) said it will change its name to Filana Therapeutics, reflecting its focus on developing drugs that target the filamin A protein to treat central nervous system disorders. The ...
From reducing administrative workload to navigating ‘alien intelligence,’ this month’s column takes a practical look at ...
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results